Emami (531162) Hisse Özeti
Emami Limited, Hindistan'da ve uluslararası alanda kişisel ve sağlık ürünleri üretmekte ve pazarlamaktadır. Daha fazla detay
| Kar Tanesi Skoru | |
|---|---|
| Değerleme | 3/6 |
| Gelecekteki Büyüme | 2/6 |
| Geçmiş Performans | 3/6 |
| Finansal Sağlık | 6/6 |
| Temettüler | 6/6 |
Ödüller
Risk Analizi
Risk kontrollerimizden 531162 için herhangi bir risk tespit edilmedi.
531162 Community Fair Values
Create NarrativeSee what 8 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Emami Limited Rakipler
Fiyat Geçmişi ve Performans
| Tarihsel hisse senedi fiyatları | |
|---|---|
| Güncel Hisse Fiyatı | ₹390.95 |
| 52 Haftanın En Yüksek Seviyesi | ₹634.65 |
| 52 Haftanın En Düşük Seviyesi | ₹376.05 |
| Beta | 0.15 |
| 1 Aylık Değişim | -8.78% |
| 3 Aylık Değişim | -5.99% |
| 1 Yıllık Değişim | -31.67% |
| 3 Yıllık Değişim | -2.88% |
| 5 Yıllık Değişim | -28.17% |
| Halka arzdan bu yana değişim | 16,595.39% |
Son Haberler & Güncellemeler
531162: Trimmed Fair Value And Rich Future P/E Will Shape Measured Outlook
Analysts have trimmed their price target on Emami from ₹425.00 to ₹415.00, reflecting updates to their models that now factor in different assumptions for the discount rate, revenue growth, profit margin and future P/E. What's in the News A board meeting is scheduled for May 21, 2026, at 12:00 Indian Standard Time to consider and approve the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026.
531162: Upcoming May Results And Board Decisions Will Support Bullish Outlook
Analysts have trimmed their fair value estimate for Emami from ₹800 to about ₹745, citing updated assumptions that include slightly higher revenue growth expectations, along with a lower projected profit margin and a reduced future P/E multiple. What's in the News Board meeting scheduled for May 21, 2026, at 12:00 Indian Standard Time to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026 (company filing).531162: Upcoming Results And Higher Board Meeting Focus Will Support Bullish Outlook
Analysts have raised their price target on Emami from ₹775.37 to ₹800.00, reflecting updated assumptions around discount rates, revenue growth, profit margins, and future P/E multiples. What's in the News Emami has scheduled a board meeting for May 21, 2026.Recent updates
531162: Trimmed Fair Value And Rich Future P/E Will Shape Measured Outlook
Analysts have trimmed their price target on Emami from ₹425.00 to ₹415.00, reflecting updates to their models that now factor in different assumptions for the discount rate, revenue growth, profit margin and future P/E. What's in the News A board meeting is scheduled for May 21, 2026, at 12:00 Indian Standard Time to consider and approve the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026.531162: Upcoming May Results And Board Decisions Will Support Bullish Outlook
Analysts have trimmed their fair value estimate for Emami from ₹800 to about ₹745, citing updated assumptions that include slightly higher revenue growth expectations, along with a lower projected profit margin and a reduced future P/E multiple. What's in the News Board meeting scheduled for May 21, 2026, at 12:00 Indian Standard Time to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026 (company filing).531162: Upcoming Results And Higher Board Meeting Focus Will Support Bullish Outlook
Analysts have raised their price target on Emami from ₹775.37 to ₹800.00, reflecting updated assumptions around discount rates, revenue growth, profit margins, and future P/E multiples. What's in the News Emami has scheduled a board meeting for May 21, 2026.531162: Interim Dividend Will Be Insufficient To Offset Rich Future P/E
Analysts have cut their price target on Emami from about ₹453 to ₹425, reflecting updated assumptions for slightly higher revenue growth, a marginally higher discount rate, and a lower future P/E multiple. What's in the News Board meeting scheduled for May 21, 2026, to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026 (company filing).531162: Interim Dividend And Revised Assumptions Will Support A Balanced Outlook
Analysts have trimmed their price target on Emami from ₹510 to about ₹453, pointing to updated assumptions around a lower future P/E multiple, an adjusted discount rate, and revised expectations for revenue growth and profit margins. What's in the News The board of directors declared a 2nd interim dividend of ₹6 per equity share of face value ₹1 each, described as 600% on 436,500,000 equity shares for the financial year 2025-26 (Key Developments).531162: Second Interim Dividend Will Support Bullish Long Term Outlook
Analysts have trimmed their price target on Emami by about ₹31 to reflect updated assumptions around fair value, discount rate, revenue growth, profit margin, and future P/E expectations. What's in the News The board approved a second interim dividend of ₹6 per equity share of ₹1 each, equal to 600% on 436,500,000 equity shares for FY 2025-26, with the record date set for 10 February 2026 and payment scheduled on or before 6 March 2026 (Key Developments).
531162: February Dividend And Board Review Will Support Bullish Outlook
Analysts have trimmed their fair value estimate for Emami to ₹637 from ₹651, citing slightly adjusted assumptions on discount rate, revenue growth, profit margin and future P/E that point to a marginally more conservative outlook on the stock's valuation. What's in the News A board meeting on 4 February 2026 to review unaudited standalone and consolidated financial results for the quarter ended 31 December 2025 and to consider a 2nd interim dividend for FY 2025-26 (company filing).531162: Interim Dividend And Stable Assumptions Will Support A Balanced Outlook
Analysts have maintained their fair value estimate for Emami at ₹510. They have made only minor adjustments to assumptions such as discount rate, revenue growth, profit margin and future P/E, which feed into the updated price target rationale.531162: Board Review And Interim Dividend Will Shape A Balanced Outlook
Analysts have trimmed their price target for Emami from ₹540.54 to ₹510.00, citing refreshed assumptions that include slight adjustments to revenue growth, profit margins and the future P/E multiple under a marginally lower discount rate. What's in the News Emami has scheduled a board meeting on Feb 04, 2026 to review unaudited standalone and consolidated financial results for the quarter ended 31 December, 2025 (Key Developments).531162: February Board Meeting And Dividend Decision Will Reinforce Bullish Outlook
Analysts have trimmed their price target for Emami slightly to ₹651 from about ₹653. The adjustment reflects small tweaks to their fair value, discount rate, revenue growth and profit margin assumptions, alongside a marginally lower expected future P/E multiple.531162: February Dividend Decision Will Support Bullish Long-Term View
Analysts have made only a minor adjustment to their price view on Emami, with the updated fair value at ₹653.25. A slightly lower discount rate, along with revised assumptions for revenue growth, profit margin, and future P/E, serve to fine tune rather than overhaul the prior framework.531162: Upcoming Dividend Decision Will Support Bullish Long Term Outlook
Analysts have trimmed their price target on Emami from ₹883 to ₹807. This reflects slightly lower margin and valuation expectations that more than offset modestly stronger projected revenue growth and a reduced discount rate.531162: Interim Dividend Decision At November Meeting Will Support Bullish Outlook
Analysts have nudged their price target on Emami slightly higher to align with a fair value of ₹653.25. This reflects marginally lower perceived risk and a steady outlook on growth, margins, and future valuation multiples.531162: Board Will Consider Interim Dividend At November 10 Results Meeting
Analysts have revised their price target for Emami down from ₹697.96 to ₹653.25. They cite updated assessments of the company's growth prospects and valuation metrics as reasons for the change.531162: Board To Weigh Interim Dividend At November 10 Meeting
Analysts have slightly revised their price target for Emami downward from ₹706.24 to ₹697.96. This change reflects minor adjustments in growth and profitability expectations.
Relaunching Fair And Handsome And Capitalizing On Dermicool Innovations Will Propel Earnings Growth
Strategic relaunches and product innovations aim to boost revenue, particularly in Fair and Handsome, Kesh King, Dermicool, and BoroPlus Soft segments.Hissedar Getirileri
| 531162 | IN Personal Products | IN Pazar | |
|---|---|---|---|
| 7D | 1.5% | 2.0% | -2.1% |
| 1Y | -31.7% | -9.5% | -4.6% |
Getiri vs. Endüstri: 531162 geçen yıl % -9.5 oranında getiri sağlayan Indian Personal Products sektörünün gerisinde kaldı.
Getiri vs Piyasa: 531162 geçen yıl % -4.6 oranında getiri sağlayan Indian Piyasasının altında performans gösterdi.
Fiyat Oynaklığı
| 531162 volatility | |
|---|---|
| 531162 Average Weekly Movement | 4.1% |
| Personal Products Industry Average Movement | 4.7% |
| Market Average Movement | 7.1% |
| 10% most volatile stocks in IN Market | 10.2% |
| 10% least volatile stocks in IN Market | 4.7% |
İstikrarlı Hisse Senedi Fiyatı: 531162 son 3 ayda Indian piyasasına kıyasla önemli bir fiyat oynaklığı yaşamadı.
Zaman İçindeki Volatilite: 531162 'nin haftalık oynaklığı ( 4% ) son bir yıldır istikrarlı seyretti.
Şirket Hakkında
| Kuruldu | Çalışanlar | CEO | Web sitesi |
|---|---|---|---|
| 1974 | 3,217 | Harsha Agarwal | www.emamiltd.in |
Emami Limited, Hindistan'da ve uluslararası alanda kişisel ve sağlık ürünleri üretmekte ve pazarlamaktadır. Boroplus markası altında ayurvedik antiseptik krem, dikenli ısı tozu, doodh kesar vücut losyonu, aloe neem losyonu, vasocare bitkisel vazelin, hindistancevizi yağı, aloe vera jeli ve hijyen ürünleri sunmaktadır; Navratna markası altında cool oil, extra thanda, gold ayurvedic oil, therapy ayurvedic body massage and stress relief oil, maxx cool talc ve cool talc; ve Zandu markası altında balm, balm ultra-power, quick relief roll-on, ortho vedic oil, merhem, relief jel ve sprey, sağlık ürünleri, pancharishta, nityam ve kesari jivan. Şirket ayrıca Fair and Handsome markası altında erkekler için ışıltı kremi ve anında ışıltı veren yüz yıkama ürünü; Kesh King markası altında saç bakım ürünleri ve şampuan; Mentho Plus markası altında balsam; Dermicool markası altında isilik tozu; Emami 7 Oils in One markası altında saç yağı, şampuanlar ve saç kremleri; HE markası altında deodorantlar sunmaktadır; Emami Diamond Shine markası altında saç boyaları; Emami Golden Beauty markası altında talk; Emami Naturally Fair markası altında bitkisel parlaklık kremi; Ayucare markası altında diş macunu; Emami Gold markası altında saç boyaları ve yağları; ve Cream21 markası altında nemlendiriciler, losyon, yumuşak kremler, gliserinli kremler ve yağlar, vazelin, bebek şampuanları ve diğer cilt ürünleri.
Emami Limited Temel Bilgiler Özeti
| 531162 temel i̇stati̇sti̇kler | |
|---|---|
| Piyasa değeri | ₹168.84b |
| Kazançlar(TTM) | ₹7.75b |
| Gelir(TTM) | ₹37.80b |
531162 aşırı değerli mi?
Gerçeğe Uygun Değer ve değerleme analizine bakınızKazanç ve Gelir
| 531162 gelir tablosu (TTM) | |
|---|---|
| Gelir | ₹37.80b |
| Gelir Maliyeti | ₹11.38b |
| Brüt Kâr | ₹26.42b |
| Diğer Giderler | ₹18.66b |
| Kazançlar | ₹7.75b |
Son Raporlanan Kazançlar
Mar 31, 2026
Sonraki Kazanç Tarihi
n/a
| Hisse başına kazanç (EPS) | 17.76 |
| Brüt Marj | 69.89% |
| Net Kâr Marjı | 20.51% |
| Borç/Özkaynak Oranı | 4.2% |
531162 uzun vadede nasıl bir performans gösterdi?
Geçmiş performansı ve karşılaştırmayı görünTemettüler
Şirket Analizi ve Finansal Veri Durumu
| Veri | Son Güncelleme (UTC saati) |
|---|---|
| Şirket Analizi | 2026/06/12 12:00 |
| Gün Sonu Hisse Fiyatı | 2026/06/12 00:00 |
| Kazançlar | 2026/03/31 |
| Yıllık Kazançlar | 2026/03/31 |
Veri Kaynakları
Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.
| Paket | Veri | Zaman Çerçevesi | Örnek ABD Kaynağı * |
|---|---|---|---|
| Şirket Finansalları | 10 yıl |
| |
| Analist Konsensüs Tahminleri | +3 yıl |
|
|
| Piyasa Fiyatları | 30 yıl |
| |
| Sahiplik | 10 yıl |
| |
| Yönetim | 10 yıl |
| |
| Önemli Gelişmeler | 10 yıl |
|
* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.
Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.
Analiz Modeli ve Kar Tanesi
Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına GitHub sayfamızdan ulaşabilirsiniz, ayrıca raporlarımızı nasıl kullanacağınızı anlatan kılavuzlarımız ve Youtube'da eğitim videolarımız da bulunmaktadır.
Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.
Endüstri ve Sektör Metrikleri
Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.
Analist Kaynakları
Emami Limited 43 Bu analistlerden 21, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.
| Analist | Kurum |
|---|---|
| Parin Tanna | 360 ONE Capital Market Private Limited |
| null null | Anand Rathi Shares and Stock Brokers Limited |
| Ajay Thakur | Anand Rathi Shares and Stock Brokers Limited |